Madrigal Pharmaceuticals
Commercializes Rezdiffra and develops combination therapies for MASH.
$533.76
After-hours close−0.11 (−0.02%)
At close$533.87(−1.81%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.86 | — | — |
| Jul 2026 | −$2.68 | −$1.99 | +25.7% |
| May 2026 | −$3.61 | −$3.25 | +10.0% |
| Feb 2026 | $0.04 | −$2.57 | −6,525.0% |
| Nov 2025 | −$2.04 | −$5.08 | −149.4% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Apr 2017 | |||
| Nov 2016 | |||
| Jul 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 3, 2026 | −$0.86 | — | — | $404.2M | — | — |
| Jul 30, 2026 | −$2.68 | −$1.99 | +25.7% | $352.1M | $364.3M | +3.5% |
| May 6, 2026 | −$3.61 | −$3.25 | +10.0% | $301.1M | $311.3M | +3.4% |
| Feb 19, 2026 | $0.04 | −$2.57 | −6,525.0% | $312.5M | $321.1M | +2.8% |
| Nov 4, 2025 | −$2.04 | −$5.08 | −149.4% | $245.0M | $287.3M | +17.3% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 5, 2025 | ||||||
| May 1, 2025 | ||||||
| Feb 26, 2025 | ||||||
| Oct 31, 2024 | ||||||
| Aug 7, 2024 | ||||||
| May 7, 2024 | ||||||
| Feb 28, 2024 | ||||||
| Nov 6, 2023 | ||||||
| Aug 8, 2023 | ||||||
| May 9, 2023 | ||||||
| Feb 23, 2023 | ||||||
| Nov 3, 2022 | ||||||
| Aug 4, 2022 | ||||||
| May 9, 2022 | ||||||
| Feb 24, 2022 | ||||||
| Nov 4, 2021 | ||||||
| Aug 5, 2021 | ||||||
| May 6, 2021 | ||||||
| Feb 25, 2021 | ||||||
| Nov 5, 2020 | ||||||
| Aug 6, 2020 | ||||||
| May 7, 2020 | ||||||
| Feb 26, 2020 | ||||||
| Nov 6, 2019 | ||||||
| Aug 7, 2019 | ||||||
| May 8, 2019 | ||||||
| Feb 27, 2019 | ||||||
| Nov 6, 2018 | ||||||
| Aug 7, 2018 | ||||||
| May 8, 2018 | ||||||
| Mar 13, 2018 | ||||||
| Nov 9, 2017 | ||||||
| Aug 10, 2017 | ||||||
| May 11, 2017 | ||||||
| Apr 3, 2017 | ||||||
| Nov 14, 2016 | ||||||
| Jul 20, 2016 | ||||||
| May 10, 2016 | ||||||
| Mar 15, 2016 | ||||||
| Nov 5, 2015 | ||||||
| Aug 6, 2015 | ||||||